A rare malignant mesothelioma of the tunica vaginalis testis: A case report

Jiang,Yiqian; Cai,Yong; Xu,Xiaoping; Kong,Xiangyang; Cao,Jianhua

doi:10.3892/ol.2024.14305

A rare malignant mesothelioma of the tunica vaginalis testis: A case report

Authors:
- Yiqian Jiang
- Yong Cai
- Xiaoping Xu
- Xiangyang Kong
- Jianhua Cao
View Affiliations

Affiliations: Department of Radiotherapy, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang 311200, P.R. China, Department of Pediatrics, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang 311200, P.R. China, Department of Respiratory and Critical Care Medicine, Xiaoshan Affiliated Hospital of Wenzhou Medical University, Hangzhou, Zhejiang 311200, P.R. China
Published online on: February 23, 2024 https://doi.org/10.3892/ol.2024.14305
Article Number: 172
Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Malignant mesothelioma of the tunica vaginalis testis is a rare, highly invasive urogenital malignant tumor with no specific clinical manifestations. Reported cases of this disease are limited. Therefore, an early preoperative diagnosis is difficult. The current study presents a case of malignant mesothelioma of the tunica vaginalis testis and a literature review. A 52‑year‑old man was admitted to Xiaoshan Affiliated Hospital of Wenzhou Medical University (Hangzhou, China) in December 2022 and underwent radical resection of the right testicle and epididymis but did not undergo radiotherapy or chemotherapy. The patient was followed up for 5 months, and no recurrence or metastasis was found. The rarity of testicular mesothelioma poses a challenge to its etiology and diagnosis, which is rarely achieved preoperatively. Malignant mesothelioma of the testicular tunica vaginalis has a poor prognosis and is not sensitive to radiotherapy or chemotherapy, requiring close postoperative follow‑up. This condition is rare in clinical practice; therefore, it needs to be reported to aid clinicians' decision‑making regarding diagnosis and treatment.

View Figures

View References

1	Iczkowski KA: Malignant mesothelioma of tunica vaginalis testis: Update for 2022. Adv Anat Pathol. 30:259–261. 2023. View Article : Google Scholar : PubMed/NCBI
2	Drevinskaite M, Patasius A, Kevlicius L, Mickys U and Smailyte G: Malignant mesothelioma of the tunica vaginalis testis: A rare case and review of literature. BMC Cancer. 20:1622020. View Article : Google Scholar : PubMed/NCBI
3	Zhang N, Fu N, Peng S and Luo X: Malignant mesothelioma of the tunica vaginalis testis: A case report and literature review. Mol Clin Oncol. 7:1053–1056. 2017.PubMed/NCBI
4	von Amsberg G, Sehovic M, Hartmann M and Bokemeyer C: Diagnosis and treatment of rare testicular tumors using the example of malignant mesothelioma of the tunica vaginalis testis and Sertoli cell tumors. Urologe A. 60:872–879. 2021.(In German). View Article : Google Scholar : PubMed/NCBI
5	de Sá, Barrêto Callou Peixoto M, Bernardo Soares MK, Libânio BB, Albuquerque KS and Bacchi CE: Malignant mesothelioma of the tunica vaginalis testis: A rare cause of hydrocele. Urol Case Rep. 43:1020482022. View Article : Google Scholar : PubMed/NCBI
6	Park YJ, Kong HJ, Jang HC, Shin HS, Oh HK and Park JS: Malignant mesothelioma of the spermatic cord. Korean J Urol. 52:225–229. 2011. View Article : Google Scholar : PubMed/NCBI
7	Oshima J, Inoue H, Fukuda S, Nishimura K and Hara T: Malignant mesothelioma of the tunica vaginalis testis: A case report. Hinyokika Kiyo. 65:215–218. 2019.(In Japanese). PubMed/NCBI
8	Baqui AA, Boire NA, Baqui TT and Etwaru DJ: Malignant mesothelioma of the tunica vaginalis Testis-A Malignancy associated with asbestos exposure and trauma: A case report and literature review. J Investig Med High Impact Case Rep. 7:23247096198273352019.PubMed/NCBI
9	Mezei G, Chang ET, Mowat FS and Moolgavkar SH: Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis. Scand J Work Environ Health. 47:85–86. 2021. View Article : Google Scholar : PubMed/NCBI
10	Arda E, Arıkan MG, Cetin G, Kuyumcuoğlu U and Usta U: Malignant mesothelioma of tunica vaginalis testis: Macroscopic and microscopic features of a very rare malignancy. Cureus. 9:e18602017.PubMed/NCBI
11	Yang LH, Yu JH, Xu HT, Lin XY, Liu Y, Miao Y, Wang L, Fan CF, Jiang GY, Ding SL, et al: Mesothelioma of the tunica vaginalis testis with prominent adenomatoid features: A case report. Int J Clin Exp Pathol. 7:7082–7087. 2014.PubMed/NCBI
12	Barbera V and Rubino M: Papillary mesothelioma of the tunica vaginalis. Cancer. 10:183–189. 1957. View Article : Google Scholar : PubMed/NCBI
13	Plas E, Riedl CR and Pflüger H: Malignant mesothelioma of the tunica vaginalis testis: Review of the literature and assessment of prognostic parameters. Cancer. 83:2437–2446. 1998. View Article : Google Scholar : PubMed/NCBI
14	Trenti E, Palermo SM, D'Elia C, Elia C, Comploj E and Pycha A, Carella R and Pycha A: Malignant mesothelioma of tunica vaginalis testis: Report of a very rare case with review of the literature. Arch Ital Urol Androl. 90:212–214. 2018. View Article : Google Scholar : PubMed/NCBI
15	Spiess PE, Tuziak T, Kassouf W, Grossman HB and Czerniak B: Malignant mesothelioma of the tunica vaginalis. Urology. 66:397–401. 2005. View Article : Google Scholar : PubMed/NCBI
16	Karabacakoğlu B, Kısa E, Özbilen MH, Karademir B, Yardım S, Çelik O, Süelözgen T and İlbey YÖ: Malignant mesothelioma of tunica vaginalis: Two extremely rare case reports. Urologia. 90:422–425. 2023. View Article : Google Scholar : PubMed/NCBI
17	Chys B, De Graeve N and Merckx L: Well differentiated papillary mesothelioma of the tunica vaginalis: Case report. Acta Chir Belg. 123:555–558. 2023. View Article : Google Scholar : PubMed/NCBI
18	Mezei G, Chang ET, Mowat FS and Moolgavkar SH: Epidemiology of mesothelioma of the pericardium and tunica vaginalis testis. Ann Epidemiol. 27:348–359.e11. 2017. View Article : Google Scholar : PubMed/NCBI
19	Kazaz IO, Teoman AS and Mungan S: Mesothelioma of the tunica vaginalis testis: A case report. Indian J Pathol Microbiol. 63:475–477. 2020. View Article : Google Scholar : PubMed/NCBI
20	Ahmed Z, Singh S, Mangal A and Mittal A: Primary malignant mesothelioma of the spermatic cord. BMJ Case Rep. 2016:bcr20162146022016. View Article : Google Scholar : PubMed/NCBI
21	Hai B, Yang Y, Xiao Y, Li B and Chen C: Diagnosis and prognosis of malignant mesothelioma of the tunica vaginalis testis. Can Urol Assoc J. 6:E238–E241. 2012. View Article : Google Scholar : PubMed/NCBI
22	Chekol SS and Sun CC: Malignant mesothelioma of the tunica vaginalis testis: Diagnostic studies and differential diagnosis. Arch Pathol Lab Med. 136:113–117. 2012. View Article : Google Scholar : PubMed/NCBI
23	Nazemi A, Nassiri N, Pearce S and Daneshmand S: Testicular mesothelioma: An analysis of epidemiology, patient outcomes, and prognostic factors. Urology. 126:140–144. 2019. View Article : Google Scholar : PubMed/NCBI
24	Guney N, Basaran M, Karayigit E, Müslümanoglu A, Guney S, Kilicaslan I and Gulbarut S: Malignant mesothelioma of the tunica vaginalis testis: A case report and review of the literature. Med Oncol. 24:449–452. 2007. View Article : Google Scholar : PubMed/NCBI
25	Candura SM, Canto A, Amatu A, Gerardini M, Stella G, Mensi M and Poggi G: Malignant mesothelioma of the tunica vaginalis testis in a petrochemical worker exposed to asbestos. Anticancer Res. 28:1365–1368. 2008.PubMed/NCBI
26	Arslan A, Ozcakir-Tomruk C, Deniz E and Akin O: A case report of metastasis of malignant mesothelioma to the retromolar trigone. World J Surg Oncol. 14:1882016. View Article : Google Scholar : PubMed/NCBI
27	Recabal P, Rosenzweig B, Bazzi WM, Carver BS and Sheinfeld J: Malignant mesothelioma of the tunica vaginalis testis: Outcomes following surgical management beyond radical orchiectomy. Urology. 107:166–170. 2017. View Article : Google Scholar : PubMed/NCBI
28	Ceresoli GL, Zucali PA, Mencoboni M, Botta M, Grossi F, Cortinovis D, Zilembo N, Ripa C, Tiseo M, Favaretto AG, et al: Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma. Br J Cancer. 109:552–558. 2013. View Article : Google Scholar : PubMed/NCBI
29	Borrelli EP and McGladrigan CG: A review of pharmacologic management in the treatment of mesothelioma. Curr Treat Options Oncol. 22:142021. View Article : Google Scholar : PubMed/NCBI